Ocumetics reports 12-month follow-up for first-in-human Group One patients
Ocumetics says its first-in-human Group One clinical patients have reached their 12-month follow-up milestone.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.